From the January 1, 2007 issue of American Family Physician (AAFP):
2007 Childhood and Adolescent Immunization Schedules - Evolution or Intelligent Design?
“The first childhood immunization schedule was released in 1983 and provided guidance to physicians as to which of the four vaccines recommended at the time (i.e., diphtheria and tetanus toxoids and pertussis [DTP], oral poliovirus vaccine [OPV], measles, mumps, and rubella [MMR], and tetanus and diphtheria toxoid [Td]) to administer at each of seven age ranges (i.e., two, four, six, 15, and 18 months, four to six years, and 14 to 16 years). All told, a child born in 1983 would receive 11 vaccine doses between birth and 18 years of age…
…The recommended schedule continues to provide guidance to busy physicians. Today, American children receive 39 recommended vaccine doses by age 18, a 3.5-fold increase over the past 25 years. This explosion of antigens has been associated with a 6.3-fold increase in vaccination-related costs. The estimated 1983 private market cost for one child to receive all recommended vaccines was $254 (adjusted to present day, excluding administrative costs); this amount has grown to $1,601 ($1,744 when optional annual influenza vaccine is added for children six to 18 years of age).2 The vaccine cost alone to fully immunize each U.S. birth cohort (approximately 4 million children) is an estimated $6.4 billion.”
PDF of the 2007 Recommended Child Immunization Schedule

Concerns
Evolution or Intelligent Design? Are those our only two choices?
11 vaccine doses in 1983 vs. 39 doses today. Wow.
I’m not necessarily anti-vaccine. There are some pretty terrible diseases out there (e.g., polio). However, that sure is an amazing increase in antigen exposure over a very short period of time.
My health concerns are two-fold:
1. The cumulative toxin exposure, e.g.:
2. The potential immune system imbalances created by both the increased number of vaccine antigens injected into young children and the interactions between them.
Financial Incentives
As noted above in the AAFP article excerpt, the pharmaceutical industry’s financial incentives for expanding vaccination schedules are significant. $254 in revenue per child in 1983 vs. $1,601 today.
This recent article in the LA Times describes the “renaissance” in vaccine development:
Breakthroughs in technology, increased funding and higher profits are spurring a boom in vaccine discovery and development that could save or improve the lives of millions of people by attacking such scourges as cancer and malaria …
… “It’s clear there is a renaissance going on around vaccines,” said Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases. “We have made more progress with some [vaccines] in the past few years than we have in the past 30.” …
… Perhaps the best evidence of a vaccine revival is that the pharmaceutical industry is returning to the market …
… Overall, the number of vaccines in development has risen from 285 in 1996 to 450 today.
Drug executives say they can charge considerably more for today’s vaccines — up to several hundred dollars or more — versus a few dollars for older vaccines.
Might financial incentives and political influence be driving the introduction of some of these vaccines?:
Texas Governor orders anti-cancer vaccine
“Perry has ties to Merck and Women in Government. One of the drug company’s three lobbyists in Texas is Mike Toomey, Perry’s former chief of staff. His current chief of staff’s
mother-in-law, Texas Republican state Rep. Dianne White Delisi, is a state director for Women in Government.
The governor also received $6,000 from Merck’s political action committee during his re-election campaign.”
Bottom Line
I’d like to see greater study into the potential interaction between the different vaccine antigens and the effects on the immune system. Creating products that help most people with the risk of potential harm to a small subset of people doesn’t seem like such a good bet when you’re one of the people in the small subset.
With autism and developmental disorders continuing to skyrocket (record numbers in California in 2006 — a topic I’ll cover in a separate future post), we need to better understand the potential risks created by these greatly expanded vaccination schedules.
In this blog, I regularly raise the topic of vaccines and potential toxin and immune injury. The reasoning is that:
- These injuries affect potentially millions of people in both acute and subclinical ways, with effects that may last lifetimes.
- The emotional and financial costs of helping family members deal with these illnesses are extremely high.
- Nutritional and other biomedical interventions can play a significant role in helping people to heal and recover.